| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,918 | 16,143 | 16,593 | 17,204 | | Cost of Revenue | 2,512 | 2,823 | 3,150 | 3,366 | | | Gross Profit |
-
| 13,320 | 13,443 | 13,838 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,079 | 8,992 | 8,924 | 7,856 | | Non Recurring |
-
|
-
|
-
| 43,291 | | Others | 3,775 | 2,984 | 2,424 | 2,199 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 1,344 | 2,095 | (39,508) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,552 | 1,344 | 2,095 | (39,508) | | Interest Expense | 1,072 | 1,055 | 1,189 | 1,440 | | Income Before Tax | 480 | 289 | 906 | (40,948) | | Income Tax Expense | (19) | (80) | 147 | 678 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 499 | 369 | 759 | (41,626) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 499 | 369 | 759 | (41,626) | | Preferred Stock And Other Adjustments | (290) | (360) |
-
|
-
| | | Net Income Applicable To Common Shares | $209 | $9 | $759 | ($41,626) |
|
0.03% Nasdaq 0.00%
Income Statement
